AbbVie to spend $380M on two 2 manufacturing facilities in Illinois

Group 1 - AbbVie is committing $100 billion to U.S.-based research and development, including manufacturing, over the next decade [3] - The company plans to significantly expand its active pharmaceutical ingredients (API) manufacturing capabilities in the U.S. [4] - AbbVie is constructing a $195 million API manufacturing facility in North Chicago to bring production back from Europe and Asia [5] Group 2 - AbbVie will acquire a device manufacturing facility in Arizona and invest in its Massachusetts facility, with further investments anticipated in 2026 [6] - Other pharmaceutical companies, such as Johnson & Johnson and AstraZeneca, are also making significant investments in U.S. manufacturing [7] - AbbVie plans to spend $380 million to build two new facilities in North Chicago, integrating advanced manufacturing technologies and AI, with construction starting in spring 2026 [8]